A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery ...

A Relative Strength Rating upgrade for Takeda Pharmaceutical ADR shows improving technical performance. Will it continue?

Persistent pharmaceutical residues such as carbamazepine are increasingly detected in natural waters, posing long-term ecological and human health risks due to their resistance to conventional ...

"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

In today’s Pharmaceutical Executive Daily, the FDA moves to limit regulation of non-medical fitness wearables, industry ...

In this article, we discuss the 15 best pharmaceutical stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Pharmaceutical Stocks to Invest In.

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...

Alnylam Pharmaceuticals has announced a $250 million investment to expand its manufacturing facility in Massachusetts. The ...

While Ultragenyx Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more ...

As of Monday, December 29, Ultragenyx Pharmaceutical Inc.’s RARE share price has dipped by 44.76%, which has investors ...